Results 11 to 20 of about 68,882 (316)
Thrombotic microangiopathy in children [PDF]
Pediatric Nephrology, 2022 The syndrome of thrombotic microangiopathy (TMA) is a clinical-pathological entity characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end organ involvement.
L. Palma +4 more
semanticscholar +4 more sources
Thrombotic Microangiopathy and the Kidney. [PDF]
Clinical Journal of the American Society of Nephrology, 2017 Thrombotic microangiopathy can manifest in a diverse range of diseases and is characterized by thrombocytopenia, microangiopathic hemolytic anemia, and organ injury, including AKI.
V. Brocklebank, K. Wood, D. Kavanagh
semanticscholar +5 more sources
Pulmonary tumor thrombotic microangiopathy: a systematic review. [PDF]
Pulmonary Circulation, 2019 Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal disease process in which pulmonary hypertension (PH) develops in the setting of malignancy.
Ben Khelil M +8 more
core +2 more sources
Nature Biomedical Engineering, 2023 Skin-microangiopathy phenotypes can be correlated with diabetes stage by leveraging clinically explainable morphophysiological features obtained from the analysis, via machine learning, of raster-scan optoacoustic mesoscopy images of skin on the leg ...
A. Karlas +14 more
semanticscholar +1 more source
Renal Thrombotic Microangiopathy: A Review.
American Journal of Kidney Diseases, 2022 Thrombotic microangiopathy (TMA) is a pathological lesion observed in a wide spectrum of diseases, triggered by endothelial injury and/or dysfunction. Although TMA lesions are often accompanied by clinical features of microangiopathic hemolytic anemia ...
D. Genest +4 more
semanticscholar +1 more source
Diagnosis and treatment of thrombotic microangiopathy
International Journal of Laboratory Hematology, 2022 Thrombotic microangiopathy (TMA) is characterized by thrombocytopenia, microangiopathic haemolytic anaemia and end organ damage. TMAs have varying underlying pathophysiology and can therefore present with an array of clinical presentations.
Gemma L Thompson, D. Kavanagh
semanticscholar +1 more source
Snakebite Associated Thrombotic Microangiopathy and Recommendations for Clinical Practice
Toxins, 2022 Snakebite is a significant and under-resourced global public health issue. Snake venoms cause a variety of potentially fatal clinical toxin syndromes, including venom-induced consumption coagulopathy (VICC) which is associated with major haemorrhage.
Tina Noutsos +3 more
semanticscholar +1 more source
Bone Marrow Transplantation, 2021 Transplant-associated thrombotic microangiopathy (TA-TMA) is an increasingly recognized complication of hematopoietic stem cell transplant (HSCT) with high morbidity and mortality.
J. Young +2 more
semanticscholar +1 more source
The thrombotic microangiopathies [PDF]
Pediatric Nephrology, 2008 The term thrombotic microangiopathy (TMA) encompasses a group of conditions that are defined by, or result from, a similar histopathological lesion. Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA.
Bernard S. Kaplan, Lawrence Copelovitch
openaire +3 more sources